These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 461952)

  • 21. Pharmacokinetics of muraglitazar (BMS-298585), a dual peroxisome proliferator-activated receptors (PPAR) alpha and gamma activator, in mice, rats, dogs, and monkeys.
    Hosagrahara VP; Chandrasena G; Chang SY; Koplowitz B; Hariharan N; Cheng PT; Humphreys WG
    Xenobiotica; 2006 Dec; 36(12):1227-38. PubMed ID: 17162469
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Concentrations of phenethylamine in dog following single doses and during intravenous self-administration.
    Cone EJ; Risner ME; Neidert GL
    Res Commun Chem Pathol Pharmacol; 1978 Nov; 22(2):211-32. PubMed ID: 734213
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Levorphanol:radioimmunoassay and plasma concentration profiles in dog and man.
    Dixon R; Crews T; Mochacsi E; Inturrisi C; Foley K
    Res Commun Chem Pathol Pharmacol; 1980 Sep; 29(3):535-47. PubMed ID: 7423026
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of flunixin meglumine in dogs.
    Hardie EM; Hardee GE; Rawlings CA
    Am J Vet Res; 1985 Jan; 46(1):235-7. PubMed ID: 3970431
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of YM175, a new bisphosphonate, in rats and dogs.
    Usui T; Watanabe T; Higuchi S
    Drug Metab Dispos; 1995 Nov; 23(11):1214-9. PubMed ID: 8591721
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of theophylline in beagle dogs and asthmatic patients after multiple oral doses of sustained-release theophylline tablet formulation.
    Nosaka H; Takagi K; Hasegawa T; Ogura Y; Mizukami Y; Satake T
    Int J Clin Pharmacol Ther Toxicol; 1986 Oct; 24(10):528-35. PubMed ID: 3781672
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interspecies scaling of clearance and volume of distribution for digoxin-specific Fab.
    Grene-Lerouge NA; Bazin-Redureau MI; Debray M; Scherrmann JM
    Toxicol Appl Pharmacol; 1996 May; 138(1):84-9. PubMed ID: 8658517
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics and physiological effects of intravenous hydromorphone in conscious dogs.
    Guedes AG; Papich MG; Rude EP; Rider MA
    J Vet Pharmacol Ther; 2008 Aug; 31(4):334-43. PubMed ID: 18638294
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetic study on a new antiischaemic agent (BRLP-42).
    Csárdi A; Pátfalusi M; Mészáros S; Vereczkey L
    Acta Physiol Hung; 1994; 82(4):321-6. PubMed ID: 7785441
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogs.
    Thompson KL; Vincent SH; Miller RR; Colletti AE; Alvaro RF; Wallace MA; Feeney WP; Chiu SH
    Drug Metab Dispos; 1997 Oct; 25(10):1113-8. PubMed ID: 9321512
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disposition of the novel anticancer agent vinorelbine ditartrate following intravenous administration in mice, rats and dogs.
    Kobayashi S; Sakai T; Dalrymple PD; Wood SG; Chasseaud LF
    Arzneimittelforschung; 1993 Dec; 43(12):1367-77. PubMed ID: 8141830
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of biosynthetic human proinsulin following intravenous and subcutaneous administration in metabolically healthy volunteers.
    Zilker TR; Gray IP; Hales CN; Wahl K; Ermler R; Lebender A; Heinzel G; Bottermann P
    Horm Metab Res Suppl; 1988; 18():37-43. PubMed ID: 3192159
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclosporine disposition in the dog. Comparison of radioimmunoassay with high-performance liquid chromatographic assay and pharmacokinetics following intravenous administration.
    Buice RG; Gurley BJ; Stentz FB; Sidhu P; McClellan T; Williams JW
    Transplantation; 1985 Nov; 40(5):483-8. PubMed ID: 4060219
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of ethosuximide in the dog.
    el Sayed MA; Löscher W; Frey HH
    Arch Int Pharmacodyn Ther; 1978 Aug; 234(2):180-92. PubMed ID: 708147
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of clonazepam in the dog.
    Al-Tahan F; Löscher W; Frey HH
    Arch Int Pharmacodyn Ther; 1984 Apr; 268(2):180-93. PubMed ID: 6732363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Levodopa pharmacokinetics. Alterations after benserazide, a decarboxylase inhibitor.
    Doller HJ; Connor JD; Lock DR; Sloviter RS; Dvorchik BH; Vesell ES
    Drug Metab Dispos; 1978; 6(2):164-8. PubMed ID: 26532
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetis of alpha- and beta-isomers of racemic endosulfan following intravenous administration in rabbits.
    Gupta PK; Ehrnebo M
    Drug Metab Dispos; 1979; 7(1):7-10. PubMed ID: 35329
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radioimmunoassay of meterelin and pharmacokinetics after single injection and implant administration in dogs.
    Hudon E; Rondeau JJ; Lenaerts V; Würthrich P; Boutignon F; Deghenghi R; Marleau S; Yamaguchi N; Adam A; Ong H
    J Pharm Sci; 1997 Feb; 86(2):172-8. PubMed ID: 9040091
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aprikalim: radioimmunoassay and pharmacokinetic studies in mouse, monkey, and dog.
    Chevalier P; Rouillard C; Montay G; Frydman A
    J Pharm Sci; 1994 Mar; 83(3):372-8. PubMed ID: 8207684
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ouabain pharmacokinetics in dog and man. Determination by radioimmunoassay.
    Selden R; Smith TW
    Circulation; 1972 Jun; 45(6):1176-82. PubMed ID: 5032817
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.